Skip to content
10-Q/A

Quarterly Report

HASCO Medical, Inc.

0001161697-14-000101

← back to feed
Filed
Mar 12, 2014 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Apr 30, 2013 988.25M sh
Shares Diluted Q1 2013 · Mar 31, 2013 988.07M sh
Shares Diluted Q1 2013 · Mar 31, 2012 841.49M sh
Capex Q1 2013 · Mar 31, 2013 $122K
Capex restated Q1 2013 · Mar 31, 2012 $141.66K
Operating Cash Flow restated Q1 2013 · Mar 31, 2013 −$306.07K
Operating Cash Flow restated Q1 2013 · Mar 31, 2012 $50.6K
Long Term Debt Q1 2013 · Mar 31, 2013 $6.24M
Long Term Debt Q1 2013 · Dec 31, 2012 $6.39M
Cash And Equivalents Q1 2013 · Mar 31, 2013 $1.35M
Cash And Equivalents Q1 2013 · Dec 31, 2012 $850.39K
Cash And Equivalents Q1 2013 · Mar 31, 2012 $686.91K
Cash And Equivalents Q1 2013 · Dec 31, 2011 $212.46K
Stockholders Equity restated Q1 2013 · Mar 31, 2013 $1.5M
Stockholders Equity restated Q1 2013 · Dec 31, 2012 $1.69M
Stockholders Equity restated Q1 2013 · Mar 31, 2012 $1.44M
Current Liabilities restated Q1 2013 · Mar 31, 2013 $19.21M
Current Liabilities restated Q1 2013 · Dec 31, 2012 $18.45M
Current Liabilities restated Q1 2013 · Mar 31, 2012 $21.54M
Total Liabilities restated Q1 2013 · Mar 31, 2013 $26.27M
Total Liabilities restated Q1 2013 · Dec 31, 2012 $25.37M
Total Liabilities restated Q1 2013 · Mar 31, 2012 $29.14M
Current Assets restated Q1 2013 · Mar 31, 2013 $19.04M
Current Assets restated Q1 2013 · Dec 31, 2012 $18.63M
Current Assets restated Q1 2013 · Mar 31, 2012 $20.99M
Total Assets restated Q1 2013 · Mar 31, 2013 $27.77M
Total Assets restated Q1 2013 · Dec 31, 2012 $27.07M
Total Assets restated Q1 2013 · Mar 31, 2012 $30.58M
Sga Expense restated Q1 2013 · Mar 31, 2013 $2.69M
Sga Expense restated Q1 2013 · Mar 31, 2012 $1.24M
Net Income restated Q1 2013 · Mar 31, 2013 −$198.71K
Net Income restated Q1 2013 · Mar 31, 2012 $58.97K
Operating Income restated Q1 2013 · Mar 31, 2013 −$426.92K
Operating Income restated Q1 2013 · Mar 31, 2012 $181.64K
Gross Profit restated Q1 2013 · Mar 31, 2013 $3.26M
Gross Profit restated Q1 2013 · Mar 31, 2012 $2.02M
Cost Of Revenue restated Q1 2013 · Mar 31, 2013 $11.82M
Cost Of Revenue restated Q1 2013 · Mar 31, 2012 $6.81M
Revenue restated Q1 2013 · Mar 31, 2013 $15.07M
Revenue Q1 2013 · Mar 31, 2012 $8.83M